{
  "items": [
    {
      "title": "JNJ's Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer",
      "description": "Johnson & Johnson's niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong phase III data.",
      "published_utc": "2025-06-05T00:17:00",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=5fd8f76625cad9aa6e2e500f3a24cdf5b44cc920bc28ca17b28386c061f2e978",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 135036501,
      "datetime": 1749053820
    }
  ]
}